RR
Rajesh Rasiklal Agrawal
About Rajesh Rasiklal Agrawal
Data last updated:
Rajesh Rasiklal Agrawal is a Director at Seva Super Speciality And Critical Care Center Private Limited (since 2010) and Director at Nirnay Diagnostic And Research Center Private Limited (since 2008). The companies operate in Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹15.35 Cr; the largest is Seva Super Speciality And Critical Care Center Private Limited at ₹13.71 Cr (FY 2025). Earlier, Rajesh Rasiklal Agrawal was a Director at Raj Rajendra Suri Developers Private Limited (2009–2011).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Seva Super Speciality And Critical Care Center Private Limited U85110MH2010PTC204276 | Director | 16 Jun 2010 | 2010 | ₹13.71 Cr (FY 2025) | Active |
| Nirnay Diagnostic And Research Center Private Limited U85100MH2008PTC188009 | Director | 06 Nov 2008 | 2008 | ₹1.65 Cr (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Raj Rajendra Suri Developers Private Limited U85110MH2007PTC174753 | Director | 05 Mar 2009 | 2007 | ₹28,400 (FY 2016) | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rajesh Rasiklal Agrawal
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajesh Rasiklal Agrawal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajesh Rasiklal Agrawal
Rajesh Rasiklal Agrawal currently holds 2 directorships: Seva Super Speciality And Critical Care Center Private Limited (Director, since 16 Jun 2010, revenue ₹13.71 Cr (FY 2025)); Nirnay Diagnostic And Research Center Private Limited (Director, since 06 Nov 2008, revenue ₹1.65 Cr (FY 2024)).
Rajesh Rasiklal Agrawal was first appointed on 06 Nov 2008 as Director at Nirnay Diagnostic And Research Center Private Limited. The most recent appointment on record is 16 Jun 2010 at Seva Super Speciality And Critical Care Center Private Limited.
The 2 current companies of Rajesh Rasiklal Agrawal that report revenue have a combined latest revenue of ₹15.35 Cr: Seva Super Speciality And Critical Care Center Private Limited ₹13.71 Cr (FY 2025); Nirnay Diagnostic And Research Center Private Limited ₹1.65 Cr (FY 2024).
Rajesh Rasiklal Agrawal held 1 earlier board appointment: Raj Rajendra Suri Developers Private Limited (Director, 05 Mar 2009 to 18 Jul 2011).
The current boards of Rajesh Rasiklal Agrawal's companies include Gajendra Ramesh Ahirrao (Seva Super Speciality And Critical Care Center Private Limited), Kunal Mahendrakumar Mehta (Seva Super Speciality And Critical Care Center Private Limited), Prashant Ganesh Patil (Seva Super Speciality And Critical Care Center Private Limited), Prashant Madhukar Patil (Seva Super Speciality And Critical Care Center Private Limited), Pramod Shrikrishna Kulkarni (Nirnay Diagnostic And Research Center Private Limited), Pravin Ramesh Salunkhe (Nirnay Diagnostic And Research Center Private Limited), among others.